Home » Anacor Pharmaceuticals Announces Positive Preliminary Results from Phase IIb Trial
Anacor Pharmaceuticals Announces Positive Preliminary Results from Phase IIb Trial
Anacor Pharmaceuticals announced today preliminary results from its Phase IIb trial of AN2728 for the treatment of mild-to-moderate plaque-type psoriasis.
MarketWatch
MarketWatch
Upcoming Events
-
07May
-
14May
-
30May